# Importance of Point-of-Care Ultrasound for Early Detection of Valvular and Cardiac Diseases (IMPROVE)

Study · id `cardio:ct-nct07756398` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07756398](<https://clinicaltrials.gov/study/NCT07756398>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07756398

Browse, organ or system: Heart  
Browse, condition area: Heart failure; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1088 participants.

## Technical summary

Registry record NCT07756398. Randomized; single masking; primary purpose screening. Start 2026-12-15 (anticipated); primary completion 2028-06-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose screening
- Phase: Not applicable
- Enrolled: 1088 participants (planned count; ClinicalTrials.gov record NCT07756398, source copy `cardio:ctgov-nct07756398-2026-11-03`, retrieved 2026-11-18)
- Planned start: 2026-12-15 (anticipated) (ClinicalTrials.gov record NCT07756398, source copy `cardio:ctgov-nct07756398-2026-11-03`, retrieved 2026-11-18)
- Primary completion: 2028-06-01 (anticipated) (ClinicalTrials.gov record NCT07756398, source copy `cardio:ctgov-nct07756398-2026-11-03`, retrieved 2026-11-18)
- Completion: 2028-12-01 (anticipated) (ClinicalTrials.gov record NCT07756398, source copy `cardio:ctgov-nct07756398-2026-11-03`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT07756398, source copy `cardio:ctgov-nct07756398-2026-11-03`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07756398-2026-11-03`, retrieved 2026-11-18)

## The registry's words

- Brief title: Importance of Point-of-Care Ultrasound for Early Detection of Valvular and Cardiac Diseases (IMPROVE)
- Acronym: IMPROVE
- Condition: Valvular Heart Disease Patients
- Condition: Aortic Stenosis
- Condition: Mitral Regurgitation
- Condition: Left Ventricular Diastolic Dysfunction
- Intervention (Device): Kosmos Torso-One AI-guided Point-of-Care Ultrasound (EchoNous, Inc.)
- Lead sponsor: University of Texas Southwestern Medical Center
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Mitral regurgitation (`cardio:mitral-regurgitation`)
- Registry lists this organization as the lead sponsor: University of Texas Southwestern Medical Center (`cardio:org-university-of-texas-southwestern-medical-center`)

## Provenance

Content hash: c5a388533b0db95f8967b2e17a72fbd609112f49f3caf04f92c260680b2fb625
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
